Skip to main content
NCBI home page
Molecular Genetics & Genomic Medicine logoLink to Molecular Genetics & Genomic Medicine
. 2019 Nov 15;8(1):e1013. doi: 10.1002/mgg3.1013

Variable neurodevelopmental and morphological phenotypes of carriers with 12q12 duplications

Lynnea Myers 1, Moira Blyth 2, Kamran Moradkhani 3, Dubravka Hranilović 4, Sam Polesie 5,6, Johan Isaksson 1,7, Ann Nordgren 8,9, Maja Bucan 10, Marie Vincent 11, Sven Bölte 1,12, Britt‐Marie Anderlid 8,9, Kristiina Tammimies 1,✉
PMCID: PMC6978403  PMID: 31730283

Abstract

Background

Variable size deletions affecting 12q12 have been found in individuals with neurodevelopmental disorders (NDDs) and distinct facial and physical features. For many genetic loci affected by deletions in individuals with NDDs, reciprocal duplications have been described. However, for the 12q12 region, there are no detailed descriptions of duplication cases in the literature.

Methods

We report a phenotypic description of a family with monozygotic twins diagnosed with NDDs, carrying a 9 Mb duplication at 12q12, and five other individuals with overlapping duplications ranging from 4.54 Mb up to 15.16 Mb.

Results

The duplication carriers had language delays, cognitive delays, and were diagnosed with autism spectrum disorder. Additionally, distinct facial features (e.g., high foreheads, deeply set eyes, short palpebral fissures, small ears, high nasal bridges, abnormalities of the nose tip, thin lips), large feet, and abnormalities in the digits were noted. We also describe incomplete penetrance of the NDD phenotypes among the individuals with 12q12 duplication.

Conclusion

This case series expands our knowledge on this rare genetic aberration and suggests that large 12q12 duplications may increase the risk for developing NDDs.

Keywords: ADHD, autism spectrum disorder, chromosome 12, duplication, phenotype

We report phenotype descriptions of seven individuals with variable size duplication of 12q12 4.54 Mb up to 15.16 Mb. The duplication carriers had language delays, cognitive delays, and were diagnosed with autism spectrum disorder as well as distinct facial features. This case series expands our knowledge on this rare genetic aberration and suggests that large 12q12 duplications may increase the risk for developing neurodevelopmental disorders.

graphic file with name MGG3-8-e1013-g003.jpg

1. INTRODUCTION

Rare structural genetic variants, including copy number variation (CNV), have been identified in individuals with a variety of neurodevelopmental disorders (NDDs) such as autism spectrum disorders (ASD) and attention deficit hyperactivity disorders (ADHD) (Deshpande & Weiss, 2018;Lionel et al., 2011;Pinto et al., 2014). Additionally, rare CNVs have been shown to increase the risk for neurodevelopmental challenges, including ASD and ADHD, in the general population (Girirajan et al., 2011;Guyatt et al., 2018;Martin et al., 2019;Williams et al., 2012). Phenotypic descriptions of the carriers of the most recurrent and reciprocal CNV loci have emerged in the recent years (D'Angelo et al., 2016;Deshpande & Weiss, 2018;Hanson et al., 2015;Lowther, Costain, Baribeau, & Bassett, 2017). For clinicians involved in genetic counseling and for the affected families, it is important to expand the understanding, consequences, as well as the phenotypic spectrum associated with certain CNVs.

Previously, deletions affecting the 12q12 region have been published which delineate the associated phenotypes (Adam, Mehta, Knight, Hall, & Rossi, 2010;Carlsen, Frengen, Fannemel, & Misceo, 2015;Failla et al., 2008;Weng, Luo, & Hou, 2018). The 12q12 deletion carriers have been reported to present with intellectual disability (ID), growth restrictions, and distinctive physical features including broad forehead, low‐set ears, strabismus, down‐slanted palpebral fissures, broad or low nasal bridges, downturned corners of the mouth, small hands and feet, wide‐spaced nipples, and testicular abnormalities (Carlsen et al., 2015;Weng et al., 2018). In individuals with NDDs, many genetic loci affected by deletions have reciprocal (or similar size and location) duplications that have been described. However, for the 12q12 region, no detailed descriptions of carriers of reciprocal duplications are currently found in the literature.

We recently characterized CNVs in a Swedish twin cohort, which included a monozygotic (MZ) twin pair with a large duplication affecting the 12q12 region (Stamouli et al., 2018). Here, we report additional findings in this MZ twin pair diagnosed with ASD, ADHD and language delay, as well as family segregation of the CNV. Additionally, assessment information from four other individuals identified with a similar size and location of duplication at 12q12 through the DECIPHER database, along information from the 17‐year‐old Croatian male patient from Wang et al. (2010), are also included for better characterization of phenotypic presentation of 12q12 duplication carriers.

2. METHODS

2.1. Ethical compliance

The overall study where the twin pair was identified was approved by the regional and national ethical boards in Sweden and informed consent was obtained from the various individuals and their parents included in this case series.

2.2. Patients

We have earlier reported the MZ twin pair with a paternally inherited 9Mb duplication at 12q12 (genomic coordinates hg19, chr12:37995364–47072741) as part of the genetic study investigating CNVs in twin pairs (Stamouli et al., 2018) from the Roots of Autism and ADHD Twin Study in Sweden (RATSS; Bölte et al., 2014). The RATSS recruits twin pairs with NDDs, as well as typical development, and study procedures involve comprehensive data collection from twin pairs including medical and developmental history, physical assessments, and psychological and genetic testing (Bölte et al., 2014). A family history was collected through interview and a medical questionnaire. Carrier analyses of the additional family members were done using either quantitative polymerase chain reaction at the research laboratory or using chromosomal microarray at Sahlgrenska University Hospital. Here, we provide detailed information of the twin pairs’ phenotypes and show segregation analysis in their family. Other duplication carriers were identified through the DECIPHER database and literature. The clinicians reporting these duplications were contacted to obtain any physical, medical, and behavioral findings and a consent from the individuals and/or families to be included in the study.

3. RESULTS

3.1. Detailed phenotypic description of the affected twin pair

3.1.1. Obstetric data and early physical health

The twins were born at 37 weeks gestation via a planned cesarean section. Prenatally, excess amniotic fluid was present and Twin 1 was diagnosed with craniosynostosis. Following birth, Twin 1 underwent surgical intervention for the synostosis with postoperative complications including a seizure, brain hemorrhage, and pneumonia. Twin 2 had no birth complications. At birth, Twin 1 was 2.710 g and 47 cm and Twin 2 was 3.060 g and 48 cm. The twins had minor health issues throughout childhood. Twin 1 had one reported febrile seizure, dust mite allergy, and vision problems and Twin 2 had pollen allergy. Karyotyping of the twins was performed during early childhood, but was reported to be without abnormalities.

3.1.2. Behavioral assessments

Both twins had early developmental delays, primarily in the area of speech‐language, fine motor, and cognitive skills. In their early years, the twins had limited spoken vocabulary and comprehension of words. The twins were assessed by psychologists at several points during their childhood, diagnosed formally with ADHD at age 3, and received special education services in school. Following the psychological assessments in RATSS at age 17, both twins were diagnosed with ASD, ADHD (combined presentation), and specific phobia of darkness. Additionally, both twins presented with learning difficulties and cognitive impairments (Table 1). Physical assessments of the twins were conducted by experienced clinical geneticists using an already published procedure (Myers et al., 2017).

Table 1.

The genetic, demographic, and phenotypic characteristics of participants with 12q12 duplications and presence of features in 12q12 deletion syndrome

  Twin 1 Twin 2 Individual 1 Individual 2 Individual 3 Individual 4 Individual 5
Study site RATSS, Sweden RATSS, Sweden Wang et al., 2010 Leeds (DECIPHER ID 280346) Nantes (France) (DECIPHER ID 349,597) Lille (France) (DECIPHER ID 254078) DECIPHER ID 288184
Genetic and demographic findings
Size of aberration (bp) 9,077,378 9,077,378 4,538,000 6,191,135a 6,143,598 10,607,906 15,159,042
Inheritance Paternal Paternal NA Paternal Maternal NA NA
Sex (M = Male, F = Female) M M M M M M F
Age at examination (years) 17 17 25 5.5 4 8 NR
Weeks gestation 37 37 42 39 38 NA NA
  Count Features in 12q12del
Selected morphological findings
Abnormal head/facial shape + + − − − NA NA 2/5 +
Deeply set eyes + + − − − NA NA 2/5  
Abnormal palpebral fissures + + − + + NA NA 4/5 +
Vision problems + − − − + NA NA 2/5 +
Small ears + + − − + NA NA 3/5  
Abnormal nasal bridge + + − − − NA NA 2/5 +
Abnormality of nasal tip + + − − + NA NA 3/5  
Highly arched palate + + − − − NA NA 2/5 +
Thin upper lip vermillion + + − − − NA NA 2/5  
Toe anomalies − + − − + NA NA 2/5 +
Neurodevelopmental characteristics
Delay in gross motor skills + + NR NR + NA NA 3/3  
Delay in fine motor skills + + + NR NR NA NA 3/3  
Cognitive impairments (including ID) + + + + + NA NA 5/5 +
Speech/language delay + + + + + NA NA 5/5 +
Autism/autistic behavior + + + − + NA NA 4/5 +
Hyperactivity/ADHD + + − − − NA NA 2/5  
Open in a new tab

Abbreviations: ADHD, attention deficit hyperactivity disorders; ID, Intellectual disability; NA, Not Available; NR, Not Reported; RATSS, Roots of Autism and ADHD Twin Study in Sweden; +, Feature Present; −, Feature Not Present.

a

Minimum reported size.

3.1.3. Morphological examination

Twin 1 presented at 17 years with a high, sloping forehead, and postsurgical scars on his head following earlier craniosynostosis surgery. Twin 2 presented with a triangular face and a high, bulging forehead. In addition, both had straight eyebrows, narrow, short palpebral fissures, deeply set eyes, small ears, high nasal bridges, narrow nose tips, thin upper lips, high, arched palates, broad distances between nasolabial ridges, and wore braces. The right helix on the ear of Twin 1 was overfolded (and had been operated on), while his left ear had a thin helix. Twin 2 had attached earlobes and had short digit II bilaterally on both fingers and toes. Both twins had large, wide feet (European size 48) with pes planus and a slight sandal gap. The twins had achieved full puberty at examination. Height, weight, length, and head circumference for both twins were within the normal ranges (Table 1 and Table S1).

3.1.4. Segregation analysis and family history of affected twins

The duplication was paternally inherited and two additional family members (an older sister and her 5‐year‐old male child) were also identified as carriers of the duplication (Figure 1). None of the other carriers or noncarriers in the family had NDD diagnoses, nor reported neurodevelopmental challenges. No detailed morphological examination was performed on the other carriers in the family.

Figure 1.

Figure 1

Open in a new tab

Three‐generation pedigree of the twin pair showing duplication carriers and neurodevelopmental phenotypes

3.1.5. Summary of all identified cases of 12q12 duplications

In addition to the affected twin pair and their family reported above, we identified five additional individuals through DECIPHER and a literature search, representing a total of seven individuals with a similar size and location of the duplication (Figure 2). From DECIPHER, four individuals were identified with duplications covering approximately 70% up 100% of the original duplication in the 12q12 region identified in the twin pair. Additionally, one individual was identified in a previous study on genetic variation in ASD by Wang et al. (2010) with a smaller duplication covering just under 50% of the same region as the duplication in the twins. The identified duplications range in size from 4.54 Mb in length to 15.16 Mb, with the minimum overlapping region spanning 3.9 Mb in size and containing 11 genes (Table 1, Figure 2). For two of the five individuals, only information related to the location and size of the duplication from DECIPHER is available as the patients moved or were unable to be contacted.

Figure 2.

Figure 2

Open in a new tab

Schematic view of the 12q12 duplication region and the corresponding lengths of the duplications found in the twin pair and other five individuals described in the study, including area of minimal overlap (dashed lines) and selected genes. Gene symbols highlighted in red have been discussed in the paper

Six of the seven individuals with the duplication were males and ranged in age from 4 to 25 years at the most recent assessment. The duplications were reported to be of paternal inheritance in three individuals (including the twin pair) and maternal inheritance in one individual. In the prenatal and obstetric period, the carriers had reported intrauterine growth restriction (n = 1), failure to progress in delivery and poor fetal heart rate (n = 1), and excess amniotic fluid (n = 2) (see Table S1 for full details). All individuals were born at 37 weeks gestation or later. Two individuals were born vaginally, while three were born via cesarean section. Reported developmental issues included learning difficulties (n = 5), speech delay (n = 5), and cognitive impairment (n = 5), along with delays in fine (n = 3) and gross motor (n = 3) development (see Table 1 for further details). Four individuals (twin pair and two other individuals) either had a diagnosis of ASD or elements of autism‐like behavior and the affected twins were both diagnosed with ADHD. Physical characteristics were reported in five of the individuals (Table 1, Table S1) and include anomalies in the facial region and toe digits.

4. DISCUSSION

We provided a detailed phenotypic description of a male MZ twin pair carrying a rare 12q12 duplication together with a case series of five individuals with similar duplications. We show that all cases with detailed information available had learning difficulties, cognitive disabilities, language delay, gross motor delays, and at least one NDD ranging from ID to ASD. However, we report incomplete penetrance of the duplication carriers, including the three‐generation family of the MZ twin pair with nonsymptomatic carriers (Figure 1), which suggest that the affected family members potentially could be carriers of additional genetic risk variants or were exposed to environmental risk factors leading to more severe outcomes. Overall, we describe variability in the reported physical features and developmental issues among the carriers. In general, individuals with this duplication are primarily males with both maternal and paternal inheritance of the duplication. Potential morphological features associated with this duplication are primarily limited to those present in the twin pair with the most detailed examinations (Table 1, Table S1). However, two features, small ears and abnormality of the nasal tip, were described in one additional carrier.

Several reports have been published on phenotypic characteristics of individuals with 12q12 deletion syndromes (Adam et al., 2010;Carlsen et al., 2015;Failla et al., 2008;Weng et al., 2018). Phenotypic characteristics reported for individuals with 12q12 deletion in Adam et al. (2010) and Weng et al. (2018) were compared with the individuals in this case series (Table 1). In addition to the NDD diagnoses, physical features common to individuals with both deletions and those reported here with duplications in the 12q12 region include abnormalities in head shape, forehead, eyes, vision, ears, nose, oral‐facial region, and toe digits. Chromosomal deletions result in haploinsufficency, while duplications may result in the production of excess proteins due to extra genes being present in the region (Clancy & Shaw, 2008). The resulting effects on protein production related to these aberrations may result in the similar, as well as different, phenotypic features found in 12q12 duplication and deletion carriers.

Prenatal and postnatal issues (e.g., excessive amniotic fluid in the twin pair, craniosynostosis in Twin 1, intrauterine growth restriction, etc.) may have been related to some of the phenotypic features found in individuals in this case series. For example, excessive amniotic fluid in the form of polyhydramnios can be caused by abnormal swallowing by the fetus in utero due to some type of genetic or central nervous system issue (Hara, Kikuchi, Miyachi, Sunagawa, & Takagi, 2006;Sandlin, Chauhan, & Magann, 2013). Meanwhile, craniosynostosis can lead to a variety of variations in physical appearance, including issues with eyes and digits, but these issues are generally present in syndromic craniosynostosis (Panigrahi, 2011). Meanwhile, intrauterine growth restriction has been associated with the later presence of neurodevelopmental delays (Hartkopf et al., 2018;Sharma, Shastri, & Sharma, 2016).

The CNV region reported in this paper includes several protein coding genes, of which at least three (i.e., CNTN1, ARID2, and PRICKLE1), have been implicated previously in NDDs through multiple reports. CNTN1 (Contactin 1, MIM 600016) is in the minimal overlap region for the carriers presented in this paper with 12q12 duplication, and is part of the contactin gene family from which multiple genes (i.e., CNTN4, CNTN5, and CNTN6) have been associated with the cases of ASD (Mercati et al., 2017;Zuko et al., 2013). Zuko et al. (2013) purport that contactins may play a critical role in normal brain development and individuals with mutations in these genes may present with a phenotype of ASD. ARID2 (AT‐Rich Interaction Domain 2, MIM 609539) plays a role in gene regulation through chromatin remodeling (Xu, Flowers, & Moran, 2012). Mutations affecting ARID2 were found in four cases with Coffin‐Siris syndrome 6 (MIM 617808) characterized by ID, speech delay, ADHD, and dysmorphic facial features (Shang et al., 2015). Additional reports have been published regarding individuals with ARID2 mutations and all these reports describe the presence of ID and dysmorphic features (Bramswig et al., 2017;Gazdagh et al., 2018;Zahir et al., 2016). PRICKLE1 (Prickle Planar Cell Polarity Protein 1‐MIM 608500) is believed to play an important role in nervous system development and it has been linked to early‐onset epilepsies, as well as some progressive neurological syndromes (Mastrangelo et al., 2018;U.S. National Library of Medicine, 2017). A study in mice found that mutations in PRICKLE1 resulted in ASD‐like behaviors (Paemka et al., 2013), as well as craniofacial abnormalities (Wan, Lantz, Cusack, & Szabo‐Rogers, 2018). Later, genetic variants affecting PRICKLE1 have been found in ASD cases (Cukier et al., 2014;Todd & Bassuk, 2018), demonstrating the potential role of the gene across NDDs.

In summary, we report here seven individuals with 12q12 duplication with variable NDDs along with abnormal physical features, of which some were common with the earlier described 12q12 deletion cases. There are multiple genes thought to be related to speech‐language development, ID, and ASD in the largest region affected by the 12q12 duplications region that could be causal for the phenotypes seen in the duplication cases. Further cases are needed to confirm our physical and behavioral findings and possibly support a 12q12 duplication syndrome phenotype.

AUTHOR CONTRIBUTIONS

LM and KT conceived and planned the study, and drafted the manuscript. MB, KM, DH, SP, JI, AN, MB, MV, SB, B‐MA and KT acquired clinical phenotype data and/or analyzed genetic material. LM with help of AN, B‐MA and KT did the final analyzes of the clinical data. All authors provided critical feedback on the analysis and manuscript, and approved the final version.

DATA AVAILABILITY STATEMENT

All available clinical data are shared in the article. The raw genetic data that support the findings of this study are available on request and clearance from the ethical board from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Supporting information

 

Click here for additional data file. (118.4KB, pdf)

ACKNOWLEDGMENTS

We acknowledge all the families who participated in this study from the various sites, including the extended family of the affected twin pair. We also thank Sophia Stamouli, Elin Vahlgren, Torkel Carlsson, Karl Lundin, and Charlotte Willfors for their valuable contributions related to the work presented in this study. The authors state that they do not have any conflict of interest to declare in relation to this manuscript.

Myers L, Blyth M, Moradkhani K, et al. Variable neurodevelopmental and morphological phenotypes of carriers with 12q12 duplications. Mol Genet Genomic Med. 2020;8:e1013 10.1002/mgg3.1013

Funding information

Brainview grant agreement n° 642996; Innovative Medicines Initiative Joint Undertaking (Grant Agreement Number 115300); Swedish Brain Foundation (Hjärnfonden); the Harald and Greta Jeanssons Foundations, Åke Wiberg Foundation, Swedish Research Council, Swedish Foundation for Strategic Research and the Strategic Neuroscience Program at Karolinska Institutet.

REFERENCES

  1. Adam, M. P. , Mehta, A. , Knight, L. , Hall, D. E. , & Rossi, M. R. (2010). A family with a 1.17 Mb deletion of 12q12: Refining genotype‐phenotype correlation. American Journal of Medical Genetics Part A, 152A, 2394–2398. 10.1002/ajmg.a.33570 [DOI] [PubMed] [Google Scholar]
  2. Bölte, S. , Willfors, C. , Berggren, S. , Norberg, J. , Poltrago, L. , Mevel, K. , … Lichtenstein, P. (2014). The roots of autism and ADHD twin study in Sweden (RATSS). Twin Research and Human Genetics, 17, 164–176. 10.1017/thg.2014.12 [DOI] [PubMed] [Google Scholar]
  3. Bramswig, N. C. , Caluseriu, O. , Lüdecke, H.‐J. , Bolduc, F. V. , Noel, N. C. L. , Wieland, T. , … Wieczorek, D. (2017). Heterozygosity for ARID2 loss‐of‐function mutations in individuals with a Coffin‐Siris syndrome‐like phenotype. Human Genetics, 136, 297–305. 10.1007/s00439-017-1757-z [DOI] [PubMed] [Google Scholar]
  4. Carlsen, E. O. , Frengen, E. , Fannemel, M. , & Misceo, D. (2015). Haploinsufficiency of ANO6, NELL2 and DBX2 in a boy with intellectual disability and growth delay. American Journal of Medical Genetics Part A, 167A, 1890–1896. 10.1002/ajmg.a.37079 [DOI] [PubMed] [Google Scholar]
  5. Clancy, S. , & Shaw, K. M. (2008). DNA deletion and duplication and the associated genetic disorders. Nature Education, 1(1), 23. [Google Scholar]
  6. Cukier, H. N. , Dueker, N. D. , Slifer, S. H. , Lee, J. M. , Whitehead, P. L. , Lalanne, E. , … Pericak‐Vance, M. A. (2014). Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders. Molecular Autism, 5, 1 10.1186/2040-2392-5-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. D’Angelo, D. , Lebon, S. , Chen, Q. , Martin‐Brevet, S. , Snyder, L. A. G. , Hippolyte, L. , … … Simons Variation in Individuals Project, C . (2016). Defining the effect of the 16p11.2 duplication on cognition, behavior, and medical comorbidities. JAMA Psychiatry, 73, 20–30. 10.1001/jamapsychiatry.2015.2123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Deshpande, A. , & Weiss, L. A. (2018). Recurrent reciprocal copy number variants: Roles and rules in neurodevelopmental disorders. Developmental Neurobiology, 78, 519–530. 10.1002/dneu.22587 [DOI] [PubMed] [Google Scholar]
  9. Failla, P. , Romano, C. , Reitano, S. , Di Benedetto, D. , Grillo, L. , Fichera, M. , & Castiglia, L. (2008). 12q12 deletion: A new patient contributing to genotype‐phenotype correlation. American Journal of Medical Genetics Part A, 146A, 1354–1357. 10.1002/ajmg.a.32280 [DOI] [PubMed] [Google Scholar]
  10. Gazdagh, G. , Blyth, M. , Scurr, I. , Turnpenny, P. D. , Mehta, S. G. , Armstrong, R. , … Joss, S. (2018). Extending the clinical and genetic spectrum of ARID2 related intellectual disability. A case series of 7 patients. European Journal of Medical Genetics., 10.1016/j.ejmg.2018.04.014 [DOI] [PubMed] [Google Scholar]
  11. Girirajan, S. , Brkanac, Z. , Coe, B. P. , Baker, C. , Vives, L. , Vu, T. H. , … Eichler, E. E. (2011). Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genetics, 7, e1002334 10.1371/journal.pgen.1002334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Guyatt, A. L. , Stergiakouli, E. , Martin, J. , Walters, J. , O'Donovan, M. , Owen, M. , … Gaunt, T. R. (2018). Association of copy number variation across the genome with neuropsychiatric traits in the general population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 177, 489–502. 10.1002/ajmg.b.32637 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hanson, E. , Bernier, R. , Porche, K. , Jackson, F. I. , Goin‐Kochel, R. P. , Snyder, L. A. G. , … … Simons Variation in Individuals Project, C . (2015). The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population. Biological Psychiatry, 77, 785–793. 10.1016/j.biopsych.2014.04.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hara, K. , Kikuchi, A. , Miyachi, K. , Sunagawa, S. , & Takagi, K. (2006). Clinical features of polyhydramnios associated with fetal anomalies. Congential Anomalies, 46, 177–179. 10.1111/j.1741-4520.2006.00125.x [DOI] [PubMed] [Google Scholar]
  15. Hartkopf, J. , Schleger, F. , Keune, J. , Wiechers, C. , Pauluschke‐Froehlich, J. , Weiss, M. , … Kiefer‐Schmidt, I. (2018). Impact of intrauterine growth restriction on cognitive and motor development at 2 years of age. Frontiers in Physiology, 9, 1278 10.3389/fphys.2018.01278 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lionel, A. C. , Crosbie, J. , Barbosa, N. , Goodale, T. , Thiruvahindrapuram, B. , Rickaby, J. , … Scherer, S. W. (2011). Rare copy number variation discovery and cross‐disorder comparisons identify risk genes for ADHD. Science Translational Medicine, 3, 95ra75 10.1126/scitranslmed.3002464 [DOI] [PubMed] [Google Scholar]
  17. Lowther, C. , Costain, G. , Baribeau, D. A. , & Bassett, A. S. (2017). Genomic disorders in psychiatry‐what does the clinician need to know? Current Psychiatry Reports, 19, 82 10.1007/s11920-017-0831-5 [DOI] [PubMed] [Google Scholar]
  18. Martin, J. , Tammimies, K. , Karlsson, R. , Lu, Y. , Larsson, H. , Lichtenstein, P. , & Magnusson, P. K. E. (2019). Copy number variation and neuropsychiatric problems in females and males in the general population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 180(6), 341–350. 10.1002/ajmg.b.32685 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mastrangelo, M. , Tolve, M. , Martinelli, M. , Di Noia, S. P. , Parrini, E. , & Leuzzi, V. (2018). PRICKLE1‐related early onset epileptic encephalopathy. American Journal of Medical Genetics Part A, 176, 2841–2845. 10.1002/ajmg.a.40625 [DOI] [PubMed] [Google Scholar]
  20. Mercati, O. , Huguet, G. , Danckaert, A. , André‐Leroux, G. , Maruani, A. , Bellinzoni, M. , … Bourgeron, T. (2017). CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders. Molecular Psychiatry, 22, 625–633. 10.1038/mp.2016.61 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Myers, L. , Anderlid, B. M. , Nordgren, A. , Willfors, C. , Kuja‐Halkola, R. , Tammimies, K. , & Bölte, S. (2017). Minor physical anomalies in neurodevelopmental disorders: A twin study. Child and Adolescent Psychiatry and Mental Health, 11, 57 10.1186/s13034-017-0195-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Paemka, L. , Mahajan, V. B. , Skeie, J. M. , Sowers, L. P. , Ehaideb, S. N. , Gonzalez‐Alegre, P. , … Bassuk, A. G. (2013). PRICKLE1 interaction with SYNAPSIN I reveals a role in autism spectrum disorders. PLoS ONE, 8, e80737 10.1371/journal.pone.0080737 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Panigrahi, I. (2011). Craniosynostosis genetics: The mystery unfolds. Indian Journal of Human Genetics, 17, 48–53. 10.4103/0971-6866.86171 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pinto, D. , Delaby, E. , Merico, D. , Barbosa, M. , Merikangas, A. , Klei, L. , … Scherer, S. W. (2014). Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. American Journal of Human Genetics, 94, 677–694. 10.1016/j.ajhg.2014.03.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sandlin, A. T. , Chauhan, S. P. , & Magann, E. F. (2013). Clinical relevance of sonographically estimated amniotic fluid volume: Polyhydramnios. Journal of Ultrasound in Medicine, 32, 851–863. 10.7863/jum.2013.32.5.851 [DOI] [PubMed] [Google Scholar]
  26. Shang, L. , Cho, M. T. , Retterer, K. , Folk, L. , Humberson, J. , Rohena, L. , & Chung, W. K. (2015). Mutations in ARID2 are associated with intellectual disabilities. Neurogenetics, 16(4), 307–314. 10.1007/s10048-015-0454-0 [DOI] [PubMed] [Google Scholar]
  27. Sharma, D. , Shastri, S. , & Sharma, P. (2016). Intrauterine growth restriction: Antenatal and postnatal aspects. Clinical Medical Insights: Pediatrics, 10, 67–83. 10.4137/CMPed.S40070 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stamouli, S. , Anderlid, B.‐M. , Willfors, C. , Thiruvahindrapuram, B. , Wei, J. , Berggren, S. , … Bölte, S. (2018). Copy number variation analysis of 100 twin pairs enriched for neurodevelopmental disorders. Twin Research and Human Genetics, 21, 1–11. 10.1017/thg.2017.69 [DOI] [PubMed] [Google Scholar]
  29. Todd, B. P. , & Bassuk, A. G. (2018). A de novo mutation in PRICKLE1 associated with myoclonic epilepsy and autism spectrum disorder. Journal of Neurogenetics, 32, 313–315. 10.1080/01677063.2018.1473862 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. U.S. National Library of Medicine . (2017). PRICKLE1 gene. Genetics Home Reference. Retrieved from https://ghr.nlm.nih.gov/gene/PRICKLE1
  31. Wan, Y. , Lantz, B. , Cusack, B. J. , & Szabo‐Rogers, H. L. (2018). Prickle1 regulates differentiation of frontal bone osteoblasts. Scientific Reports, 8, 18021 10.1038/s41598-018-36742-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wang, L.‐S. , Hranilovic, D. , Wang, K. , Lindquist, I. E. , Yurcaba, L. , Petkovic, Z.‐B. , … Bucan, M. (2010). Population‐based study of genetic variation in individuals with autism spectrum disorders from Croatia. BMC Medical Genetics, 11, 134 10.1186/1471-2350-11-134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Weng, Y. , Luo, X. , & Hou, L. (2018). Deletion at 12q12 increases the risk of developmental delay and intellectual disability. Annals of Human Genetics, 82, 482–487. 10.1111/ahg.12279 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Williams, N. M. , Franke, B. , Mick, E. , Anney, R. J. L. , Freitag, C. M. , Gill, M. , … Faraone, S. V. (2012). Genome‐wide analysis of copy number variants in attention deficit hyperactivity disorder: The role of rare variants and duplications at 15q13.3. American Journal of Psychiatry, 169, 195–204. 10.1176/appi.ajp.2011.11060822 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Xu, F. , Flowers, S. , & Moran, E. (2012). Essential role of ARID2 protein‐containing SWI/SNF complex in tissue‐specific gene expression. The Journal of Biological Chemistry, 287, 5033–5041. 10.1074/jbc.M111.279968 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zahir, F. R. , Tucker, T. , Mayo, S. , Brown, C. J. , Lim, E. L. , Taylor, J. , … Friedman, J. M. (2016). Intragenic CNVs for epigenetic regulatory genes in intellectual disability: Survey identifies pathogenic and benign single exon changes. American Journal of Medical Genetics Part A, 170, 2916–2926. 10.1002/ajmg.a.37669 [DOI] [PubMed] [Google Scholar]
  37. Zuko, A. , Kleijer, K. T. , Oguro‐Ando, A. , Kas, M. J. , van Daalen, E. , van der Zwaag, B. , & Burbach, J. P. (2013). Contactins in the neurobiology of autism. European Journal of Pharmacology, 719, 63–74. 10.1016/j.ejphar.2013.07.016 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

 

Click here for additional data file. (118.4KB, pdf)

Data Availability Statement

All available clinical data are shared in the article. The raw genetic data that support the findings of this study are available on request and clearance from the ethical board from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Articles from Molecular Genetics & Genomic Medicine are provided here courtesy of Blackwell Publishing

RESOURCES